What is the significance of the pharmacokinetic profile and potential drug–drug interactions of long-acting intramuscular cabotegravir and rilpivirine?-Reference-Cited by-同舟云学术

What is the significance of the pharmacokinetic profile and potential drug–drug interactions of long-acting intramuscular cabotegravir and rilpivirine?

Published:2023-05-04 Issue:5 Volume:19 Page:243-247
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Bettonte Sara¹²,Berton Mattia¹²,Marzolini Catia¹²³

Affiliation:

1. Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital, Basel, Switzerland

2. Faculty of Medicine, University of Basel, Basel, Switzerland

3. Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK

Funder

Swiss National Foundation

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2023.2223961

Reference20 articles.

1. US. Food and drug administration. Cabenuva product label. 2023 Mar. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212888s005s006lbl.pdf

2. European Medicines Agency. Rekambys summary of product characteristics. 2023 Mar. Available from: https://www.ema.europa.eu/en/documents/product-information/rekambys-epar-product-information_en.pdf

3. European Medicines Agency. Vocabria summary of product characteristics. 2023 Mar. Available from: https://www.ema.europa.eu/en/documents/product-information/vocabria-epar-product-information_en.pdf

4. Multiparametric magnetic resonance imaging to characterize cabotegravir long‐acting formulation depot kinetics in healthy adult volunteers

5. Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a physiologically‐based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs;CPT: Pharmacometrics & Systems Pharmacology;2024-03

2. Polypharmacy and potential drug–drug interactions among people living with HIV in the era of integrase strand-transferase inhibitor-based antiretroviral therapy;International Journal of Antimicrobial Agents;2024-02

3. Role of Modeling and Simulation in Preclinical and Clinical Long-Acting Injectable Drug Development;The AAPS Journal;2023-10-17